Research Presentation Sessions: Oncologic Imaging
RPS 2116 - Quantification of tumour response with imaging
Lectures
1
Artificial Intelligence-based response prediction in patients with muscle-invasive bladder cancer treated with neoadjuvant immunotherapy
07:00Joyce Greidanus, Amersfoort / NL
2
Baseline and post-treatment advanced MRI of extremity soft-tissue non-myxoid undifferentiated pleomorphic sarcoma
07:00Raul Fernando Valenzuela, Houston / US
3
Multi-graphical analysis of total-body 11C-MET dynamic PET in multiple myeloma patients
07:00Wenjian Gu, Shanghai / CN
4
First in-human total-body 68Ga-FAPI-04 PET kinetic modeling and parametric imaging in pancreatic and gastric cancer patient studies
07:00Xinlan Yang, Shanghai / CN
5
Assessing response to therapy in patients with bone metastases from breast cancer using the apparent diffusion coefficient
07:00Fabio Zugni, Milan / IT
6
Implementation of a novel mini-invasive electromagnetic device for real-time tracking of prostate motion in extreme hypofractionated radiotherapy treatments
07:00Valerio Pisoni, Giussano / IT
7
Does Deauville score differ between standard-timepoint and delayed-timepoint scans on total-body 18F-FDG PET/CT scans?
07:00Fatma Sen, Sacramento / US
8
Liver volumetry improves evaluation of treatment response to hepatic artery infusion chemotherapy compared to RECIST 1.1 criteria in uveal melanoma patients with liver metastases
07:00Sebastian Zensen, Essen / DE
9
Impact of low skeletal muscle mass and quality on clinical outcomes in patients with head and neck cancer undergoing (chemo)radiation
07:00Giulia Besutti, Reggio Emilia / IT
10
Visceral adiposity and sarcopenic obesity associates with impaired 3-month survival in frail older adults with cancer
07:00Antti Tolonen, Tampere / FI
11
Moderation
00:00Julien Dinkel, Munich / DE